Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dodrill, C. B.
Right arrow Articles by Troupin, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dodrill, C. B.
Right arrow Articles by Troupin, A. S.
NEUROLOGY 1991;41:141
© 1991 American Academy of Neurology

Neuropsychological effects of carbamazepine and phenytoin

A reanalysis Carl B. Dodrill, PhD and Allan S. Troupin, MD

Regional Epilepsy Center (Dr. Dodrill). University of Washington School of Medicine, Seattle, WA; and the Department of Neurology (Dr. Troupin), Louisiana State University, New Orleans, LA.

We previously reported that carbamazepine had fewer adverse neuropsychological effects than phenytoin, but it is now clear that our patients had much higher phenytoin than carbamazepine serum levels. When persons with high initial phenytoin levels were excluded, the statistical significance of all neuropsychological differences between the drugs disappeared.

Address correspondence and reprint requests to Dr. Carl B. Dodrill, Regional Epilepsy Center, Haborview Medical Center, Seattle, WA 98104.

Supported by grants NS 24823 and NS 17111 awarded by the National Institute of Neurological Disorders and Stroke, PHSDHHS. Ciba-Geigy assisted in the support of the original investigation. Warner-Lambert provided partial support of several research projects currently under way at the Regional Epilepsy Center in Seattle.

Received May 15, 1990. Accepted for publication in final form September 26, 1990.




This article has been cited by other articles:


Home page
 NeurologyHome page
A. B. Ettinger
Psychotropic effects of antiepileptic drugs
Neurology, December 12, 2006; 67(11): 1916 - 1925.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
D. Riva and M. Devoti
Carbamazepine Withdrawal in Children With Previous Symptomatic Partial Epilepsy: Effects on Neuropsychologic Function
J Child Neurol, June 1, 1999; 14(6): 357 - 362.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
R. J. Thomas
Seizures and Epilepsy in the Elderly
Arch Intern Med, March 24, 1997; 157(6): 605 - 617.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
M. L. Prevey, R. C. Delaney, J. A. Cramer, L. Cattanach, J. F. Collins, R. H. Mattson, and Department of Veterans Affairs Epilepsy Cooperativ
Effect of Valproate on Cognitive Functioning: Comparison With Carbamazepine
Arch Neurol, October 1, 1996; 53(10): 1008 - 1016.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
R. Kalviainen, M. Aikia, A. M. Saukkonen, E. Mervaala, and P. J. Riekkinen Sr
Vigabatrin vs Carbamazepine Monotherapy in Patients With Newly Diagnosed Epilepsy: A Randomized, Controlled Study
Arch Neurol, October 1, 1995; 52(10): 989 - 996.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
K. R. Smith Jr, P. M. Goulding, D. Wilderman, P. R. Goldfader, P. Holterman-Hommes, and F. Wei
Neurobehavioral Effects of Phenytoin and Carbamazepine in Patients Recovering From Brain Trauma: A Comparative Study
Arch Neurol, July 1, 1994; 51(7): 653 - 660.
[Abstract] [PDF]

Home page
 JAMAHome page
D. W. Loring and K. J. Meador
Neurobehavioral Effects of Anticonvulsants
JAMA, July 24, 1991; 266(4): 516 - 516.
[Abstract] [PDF]

Home page
 JAMAHome page
M. R. Trimble
Neurobehavioral Effects of Anticonvulsants
JAMA, March 13, 1991; 265(10): 1307 - 1308.
[Abstract] [PDF]